Acutect is a drug owned by Cis Bio International Sa. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 08, 2014. Details of Acutect's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5645815 | Radiolabled compounds for thrombus imaging |
Jul, 2014
(10 years ago) |
Expired
|
| US5508020 | Technetium-99M labeled peptides for imaging |
Apr, 2013
(11 years ago) |
Expired
|
| US5443815 | Technetium-99m labeled peptides for imaging |
Aug, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Acutect is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Acutect's family patents as well as insights into ongoing legal events on those patents.
Acutect's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Acutect's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 08, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Acutect Generics:
There are no approved generic versions for Acutect as of now.
About Acutect
Acutect is a drug owned by Cis Bio International Sa. Acutect uses Technetium Tc-99M Apcitide as an active ingredient. Acutect was launched by Cis Bio Intl Sa in 1998.
Approval Date:
Acutect was approved by FDA for market use on 14 September, 1998.
Active Ingredient:
Acutect uses Technetium Tc-99m Apcitide as the active ingredient. Check out other Drugs and Companies using Technetium Tc-99m Apcitide ingredient
Dosage:
Acutect is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| N/A | INJECTABLE | Discontinued | INJECTION |